Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
about
Protein oxidation, UVA and human DNA repairTargeting autophagy to sensitive glioma to temozolomide treatmentIn-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for NeuroradiologistsMetabolic consequences of oncogenic IDH mutationsMR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModelIDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced.Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin.Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer.Toxic metabolites, MAPK and Nrf2/Keap1 signaling pathways involved in oxidative toxicity in mice liver after chronic exposure to Mequindox.Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumoursFumonisins: oxidative stress-mediated toxicity and metabolism in vivo and in vitro.The emerging role and targetability of the TCA cycle in cancer metabolism.PT93, a novel caffeic acid amide derivative, suppresses glioblastoma cells migration, proliferation and MMP-2/-9 expression.MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.Fipronil insecticide toxicology: oxidative stress and metabolism.Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVAMetabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Solanum trilobatum L. Ameliorate Thioacetamide-Induced Oxidative Stress and Hepatic Damage in Albino RatsGenetic alterations of IDH1 and Vegf in brain tumors.Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro.Alpha-lipoic acid reduces methylmercury-induced neuronal injury in rat cerebral cortex via antioxidation pathways.Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways.Wild-type and mutated IDH1/2 enzymes and therapy responses.Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis.IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations.
P2860
Q26744266-684DBDC2-AB1D-4D8A-AC41-2882AA6677FCQ28066270-B875BD85-058A-43AF-BC85-C77AB3A6A1FAQ28069062-C205E779-3BC3-42A3-B706-B1318BC0ADA5Q28082949-C1FB61EB-5D6F-4ED0-B15A-60AD1055D3DEQ31137181-B54B81A6-133B-4FA8-B882-82D93CE64CE5Q33709922-180327B7-EE2B-4234-83D1-EDDC406A5126Q35907130-2AB5CD8D-BD94-4F98-BE63-37D7F9E92FDDQ36239445-1E49B9DA-3C4B-40B4-A164-869721D4C326Q36801721-B9500EB5-F826-4DD0-BF68-4951CEC070FEQ36805635-A6EA7190-0C7F-4FC5-9F8D-557312C3B99CQ37623500-3BEE7FE3-7C7B-49AB-9234-D6A21B67BE06Q38375735-2F52B162-485F-48CC-A9DD-0F832C95AC28Q38595317-7CF7BF5E-4729-47D3-BED2-A1C305BD9834Q38658458-DA6D39DB-E624-4C29-93A7-139EA8112AA3Q38705629-ADE687BA-F031-4BF0-AE62-452E55220648Q38715517-A8265B6A-DB83-42B5-A2B2-5DCE8C166AF4Q38861229-78AD94C6-A73D-48DC-A20A-02A798C5B6D9Q38958397-D34ADFB3-6708-4380-808C-A85451CCA30EQ39042732-6052FC86-F6AE-4E67-B18C-93CE5E2AB304Q40281311-14F0C5C1-7304-4C5C-A716-A2303A930B91Q41662719-F7E14155-1446-469C-9F0B-3D7E726AD088Q41691362-D3A48437-FE2A-4741-AF34-70297793B8C3Q46268407-54A324C9-EB7B-4FD7-9A6E-B086FBA7C8D4Q46327411-D2B7779F-5337-460D-8E9D-CBC59A672292Q46533060-A934BD26-9823-443C-848B-892625715634Q47128630-CA6F37F1-41DB-4F90-B8E2-17FA61627581Q47713415-3417963C-C7DC-43E5-A808-472F64E2645AQ50033966-950E017D-D28B-42F2-A414-512065A57B69Q51737118-423085A2-9A3D-44A4-A17C-6BE5C34F574DQ55456883-AF9F7C24-EB14-43B4-AF50-4AF48934E65EQ55515402-294290C2-6656-4B0A-9674-A015ED92CC8D
P2860
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@en
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@nl
type
label
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@en
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@nl
prefLabel
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@en
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@nl
P2093
P2860
P1433
P1476
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
@en
P2093
Baolan Sun
Daming Cui
Jinlong Shi
Lanchun Ni
P2860
P2888
P304
P356
10.1007/S13277-014-2644-Z
P577
2014-10-05T00:00:00Z